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Mitochondrial fusion and Bid-mediated
mitochondrial apoptosis are perturbed by
alcohol with distinct dependence on its
metabolism
Shamim Naghdi1, William S Slovinsky1, Muniswamy Madesh1, Emanuel Rubin1 and György Hajnóczky 1
Abstract
Environmental stressors like ethanol (EtOH) commonly target mitochondria to inﬂuence the cell’s fate. Recent literature
supports that chronic EtOH exposure suppresses mitochondrial dynamics, central to quality control, and sensitizes
mitochondrial permeability transition pore opening to promote cell death. EtOH-induced tissue injury is primarily
attributed to its toxic metabolic products but alcoholism also impairs tissues that poorly metabolize EtOH. We
embarked on studies to determine the respective roles of EtOH and its metabolites in mitochondrial fusion and tBid-
induced mitochondrial apoptosis. We used HepG2 cells that do not metabolize EtOH and its engineered clone that
expresses EtOH-metabolizing Cytochrome P450 E2 and alcohol dehydrogenase (VL-17A cells). We found that fusion
impairment by prolonged EtOH exposure was prominent in VL-17A cells, probably owing to reactive oxygen species
increase in the mitochondrial matrix. There was no change in fusion protein abundance, mitochondrial membrane
potential or Ca2+ uptake. By contrast, prolonged EtOH exposure promoted tBid-induced outer mitochondrial
membrane permeabilization and cell death only in HepG2 cells, owing to enhanced Bak oligomerization. Thus,
mitochondrial fusion inhibition by EtOH is dependent on its metabolites, whereas sensitization to tBid-induced death
is mediated by EtOH itself. This difference is of pathophysiological relevance because of the tissue-speciﬁc differences
in EtOH metabolism.
Introduction
Environmental stressors commonly rewire cellular sig-
naling pathways resulting in either the cell’s demise or
adaptation supporting survival. Many of these pathways
converge on mitochondria, which provide energy and
directly control cell survival and ion homeostasis. Mito-
chondrial dynamics is necessary to maintain mitochon-
dria in optimal condition and mitochondrial membrane
integrity is required to support cell survival.
Mitochondrial dynamics involves fusion, mediated by
MFN1/21 and OPA12 and ﬁssion, mediated by DRP1 with
the assistance of MFF, MID49/51, dynamin 2, and per-
haps FIS13. Fusion mediates the exchange of mtDNA,
proteins, and other soluble or membrane components
among mitochondria, providing critical support for vital
functions such as oxidative phosphorylation, mitophagy,
apoptosis, cell proliferation, and migration. Deletion of
MFN1/2 or OPA1 in mice is lethal4 and mutations in
MFN1/2 and OPA1 in humans are linked to nervous
system impairments like neuropathy5 and dominant optic
atrophy6,7. Some stressors alter either the amount or
the post-translational modiﬁcation of fusion proteins to
© The Author(s) 2018
OpenAccessThis article is licensedunder aCreativeCommonsAttribution 4.0 International License,whichpermits use, sharing, adaptation, distribution and reproduction
in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if
changesweremade. The images or other third partymaterial in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to thematerial. If
material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Correspondence: György Hajnóczky (gyorgy.hajnoczky@jefferson.edu)
1MitoCare Center, Department of Pathology, Anatomy and Cell Biology,
Thomas Jefferson University, Philadelphia, PA, USA
These authors contributed equally to the work: Shamim Naghdi,
William S. Slovinsky
Edited by P. Pinton
Ofﬁcial journal of the Cell Death Differentiation Association
12
34
56
78
90
()
:,;
12
34
56
78
90
()
:,;
1
2
3
4
5
6
7
8
9
0
()
:,;
12
34
56
78
90
()
:,;
perturb the ﬁssion/fusion balance, leading to either
hyperfusion or fragmentation of mitochondria, which
changes help to adjust mitochondrial functions.
Mitochondrial membrane integrity is needed for cell
survival since its loss leads to the release of mitochondrial
intermembrane space (IMS) content, which compromises
energy metabolism and activates death pathways. For
instance, mitochondrial Ca2+ overload leads to perme-
ability transition pore (PTP) formation in the inner
mitochondrial membrane (IMM) with the ensuing
damage of the outer mitochondrial membrane (OMM)
leading to cell death8. Alternatively, in mitochondrial
apoptosis, oligomerization of two pro-apoptotic Bcl-2
family proteins, Bak and Bax results in selective permea-
bilization of the OMM releasing IMS components like
cytochrome c (cyto c), Smac/Diablo to the cytosol acti-
vating caspases and other executioner enzymes. Normally,
Bak and Bax are neutralized by anti-apoptotic members
of the Bcl-2 family like Bcl-2, Bcl-xL, and Mcl-1. However,
many stressors target pro-apoptotic members of this
family like Bid, Bim, Noxa, or PUMA to activate Bak/Bax
directly or indirectly9. For instance, TNFα or Fas activates
caspase-8 to truncate Bid, a pro-apoptotic protein to tBid
that induces oligomerization of the OMM resident Bak
or enhances translocation of the cytoplasmic Bax to the
OMM where it also undergoes oligomerization to execute
OMM permeabilization (OMMP)10. Death of a cell ter-
minates its individual life, but may support survival of
the whole organism undergoing stress10.
Excessive ethanol (EtOH) consumption causes tissue
damage with 2.5 million deaths/year globally11. Alcoholic
diseases are primarily attributed to the toxic metabolites
of EtOH but more organs are affected than the ones
metabolizing EtOH. EtOH metabolites are mainly pro-
duced in the liver by two enzymes; alcohol dehydrogenase
(ADH) mainly in cytosol and Cytochrome P450 E2
(CYP2E1) in microsomes, producing acetaldehyde. Fur-
ther, aldehyde dehydrogenase in mitochondria turns
acetaldehyde into acetate and then Acetyl-CoA, utilized
in mitochondrial metabolism12. Acutely EtOH also
targets proteins and lipids in membrane and reduces
membrane integrity, whereas chronic EtOH (chrEtOH)
stiffens the membrane possibly by recruiting cholesterol13.
Reactive oxygen species (ROS), a byproduct of EtOH
metabolism, can denature proteins, break and therefore
potentiate DNA to mutate, oxidize lipids, and generate
products such as malonaldehyde and 4-hydroxynonenal14.
These adducts and acetaldehyde, the instant product of
EtOH oxidation, can further interact with biomolecules
and modulate their function. Shifting the oxidative state
of the mitochondrial matrix may compromise oxidative
phosphorylation.
Mitochondria are a primary target for EtOH toxicity
because they oxidize the highly reactive acetaldehyde and
generate ROS15. We have shown suppressed mitochon-
drial fusion in several tissues of EtOH-fed rats16,17. As
various organs differ in handling EtOH it is important
to study the mitochondrial effects in both metabolizing
and non-metabolizing conditions. To test whether the
metabolites of EtOH were involved, we have studied
here mitochondrial dynamics in HepG2 cells, which are
available both with and without EtOH-metabolizing
enzymes. Furthermore, we and others have shown that
EtOH exposure reduces mitochondrial capacity to retain
Ca2+ and promotes the Ca2+-induced PTP formation18–20
and subsequent membrane potential (ΔΨm) dissipa-
tion19,20. We here investigated the effect of EtOH stress
on the Bid/Bak pathway in the HepG2-derived cells.
Results
ChrEtOH-induced suppression of mitochondrial fusion
dynamics depends on ADH and CYP2E1
We have shown suppressed mitochondrial dynamics in
hepatocytes isolated from EtOH-fed rats17. To understand
whether this phenomenon is dependent on EtOH meta-
bolism, we used VL-17A, a hepatic cell line derived from
HepG2 cells17, stably transfected to express ADH and
CYP2E1 with high and low afﬁnity to bind and convert
EtOH to acetaldehyde (Figure S1). To compare VL-17A
with a control, two options were available, the parental
HepG2 cells, deﬁcient in ADH and CYP2E1 activity21,22
and VI-7 (that carries the empty version of 1 (Zeocin-
resistance) of the 2 vectors used to create VL-17A) that is
ADH negative23. We conﬁrmed the lack of the activity of
both ADH and CYP2E1 in VI-7 cells (Figure S1A–D).
We tested both HepG2 and VI-7 cells for mitochon-
drial morphology and dynamics using mitochondrial
matrix-targeted DsRed (mtDsRed) and photo-activatable
green ﬂuorescent protein (mtPA-GFP) as described
before24,25. Based on the ﬂuorescent protein distribution,
both HepG2 and VI-7 cells show similar mitochondrial
morphology (Figure S2A). After photoactivation, the
overall level of mitochondrial dynamic activity, which
includes fusion–ﬁssion and motility, was assessed by
measuring the spreading of the mtPA-GFP from the
photo-activated regions (Figure S2B). Because both VI-7
and HepG2 showed almost identical ﬂuorescence
spreading, in the rest of the studies of mitochondrial
dynamics, we picked only one control, HepG2, to be
compared with VL-17A cells.
VL-17A mitochondria were more elongated than
HepG2 mitochondria. Chronic exposure to EtOH did not
signiﬁcantly alter mitochondrial morphology in HepG2
cells (Fig. 1c vs a) but shortened and fragmented mito-
chondria in VL-17A cells (Fig. 1d vs b). To speciﬁcally
assess fusion state, the initial phase of the mtPA-GFP
spreading was inspected because this represents the
diffusion of mtPA-GFP among the mitochondria with
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continuous matrix. The spreading appeared slightly
slower in the EtOH-treated HepG2 and markedly sup-
pressed in the EtOH-treated VL-17A cells, indicating
suppression of dynamics (Fig. 1e, f). To quantitatively
compare the EtOH effect on both network continuity
and fusion activity in the two cell lines, mtPA-GFP
spreading values were compared at 156 s. Two-way ana-
lysis of variance (ANOVA) conﬁrmed that: (1) untreated
HepG2 shows slower spreading than untreated VL-17A
(p < 0.001); (2) the effect of EtOH was signiﬁcant only
in VL-17A (HepG2: p= 0.09, VL-17A: p < 0.001); and
(3) the effect of EtOH was signiﬁcantly larger in VL-17A
than in HepG2 cells (p < 0.001, Figure S2C black bars),
indicating that the effect of chrEtOH depends on the
presence of EtOH-metabolizing enzymes. To further
assess mitochondrial fusion, the individual events were
manually counted24,25. This revealed similar fusion
activity in both HepG2 and VL-17A cells, and upon
chrEtOH treatment, a decrease appeared in VL-17A cells
but it was not signiﬁcant (Fig. 1e, f).
Application of EtOH metabolism-altering agents restores
mitochondrial dynamics
To validate that the effect chrEtOH on mitochondrial
dynamics was promoted by its metabolism, both HepG2
and VL-17A cells were treated either with 4-
methylpyrazole (4-MP), an ADH enzyme inhibitor or
ALDA-1, an agonist for aldehyde dehydrogenase 2
(ALDH2) simultaneous with chrEtOH treatment. In the
presence of 4-MP, the EtOH effect was unaltered in
HepG2 cells (Fig. 2c vs a, S2C), but was attenuated in VL-
17A cells (Fig. 2d vs b, S2C). Similarly, treatment of the
cells with ALDA-1 did not cause a change in HepG2 cells
(Fig. 2e, S2C) but prevented the EtOH effect in VL-17A
cells (Fig. 2f, S2C). Thus, any of the 2 agents interfering
with EtOH metabolism showed rescue of mitochondrial
dynamics in EtOH-treated VL-17A cells. Collectively,
these results indicate that suppression of mitochondrial
dynamics by EtOH is directly dependent on the activity
of ADH and CYP2E1 enzymes and probably on acet-
aldehyde/ROS as the major EtOH metabolite/byproduct.
Notably, both 4-MP and ALDA-1 suppressed ﬂuorescent
protein spreading by borderline signiﬁcance in non-treated
VL-17A cells (p= 0.043 and p= 0.05), suggesting that
the basal level enzyme activity of ADH and CYP2E1
(Figure S1) and the pathway targeted by the drugs has
some stimulatory effect on mitochondrial dynamics.
EtOH treatment enhances ROS in mitochondria in VL-17A
cells to reduce mitochondria dynamics
To determine whether ROS levels are differently affec-
ted by prolonged EtOH exposure in HepG2 and VL-17A,
and to evaluate the subcellular localization of ROS, cells
were transfected with a genetically encoded probe, Grx1-
roGFP2, that measures the ratio of oxidized glutathione
(GSSG) to reduced glutathione (GSH), targeted either
to the cytoplasm or mitochondrial matrix. The ﬂuores-
cence ratio of Grx1-roGFP2 speciﬁcally measures GSSG/
GSH, reﬂecting ROS levels. As references, dithiothreitol
(DTT) was used to determine the fully reduced and H2O2
to obtain the maximally oxidized states. A representative
graph is shown in Fig. 3a and the baseline ﬂuorescence
ratios normalized to the range between DTT and H2O2
are shown for the cytoplasm in Fig. 3b and for the
mitochondrial matrix in Fig. 3c. The cytoplasmic Grx1-
roGFP2 signal indicated a more oxidizing environment
in the VL-17A than in the HepG2 cells (Fig. 3b). Neither
chronic (Fig. 3b) nor acute EtOH (Figure S2D) changed
the baseline level of cytoplasmic ROS in HepG2 and
VL-17A cells. The mitochondrial Grx1-roGFP2 signal was
similar in HepG2 and VL-17A cells in the absence
of EtOH, and was unaffected by acute EtOH addition
(Figure S2E). However, chrEtOH treatment created a
more oxidizing environment in the mitochondrial matrix
of VL-17A cells compared with HepG2 cells (Fig. 3c).
These results suggest that EtOH metabolism to acetate is
associated with ROS production that causes an oxidative
shift in the mitochondrial matrix, whereas in the absence
of ADH and CYP2E1, ROS generation is undetectable.
To test whether the ROS are relevant in the attenuation
of mitochondrial fusion, a vitamin E-derived ROS sca-
venger, Trolox, was used. Trolox rescued the EtOH-
induced suppression in VL-17A cells (Fig. 4), indicating
that ROS is responsible for suppression of mitochondrial
dynamics by prolonged EtOH in VL-17A cells.
ChrEtOH does not alter ΔΨm and Ca
2+ uptake or the
abundance of fusion proteins
Because both mitochondrial fusion and motility are
affected by ΔΨm and Ca
2+25,26, we hypothesized that
(see ﬁgure on previous page)
Fig. 1 ChrEtOH perturbs mitochondrial morphology and dynamics signiﬁcantly only in VL-17A cells. Cells were transfected with
mitochondrial matrix-targeted DsRed (mtDsRed) and mtPA-GFP. Mitochondrial morphology and GFP spreading after photoactivation in designated
areas are shown for a typical control HepG2 a and VL-17A cells b or the cells chronically treated with EtOH c, d. In the lower panels, only the green
channel is shown. e, f Spreading rate of GFP after photoactivation has been quantiﬁed and presented as the normalized ratio of mtPA-GFP to
mitoDsRed in the photo-bleached regions. e, f fusion rates were presented as the mean number of fusion events that calculated manually in the
region of interests (ROI) for 450 s. e n for control and EtOH is 27 and 29; f n for both HepG2 and EtOH is 37) (n= 4)
Naghdi et al. Cell Death and Disease  (2018) 9:1028 Page 4 of 16
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Fig. 2 Drugs altering EtOH metabolism affect the response of mitochondrial dynamics to chrEtOH only in VL-17A cells. a, b GFP spreading
in both EtOH and mock-pretreated HepG2 and VL-17A cells transfected with mtDSRed/mtPA-GFP (reproduced from Fig. 1e, f). c, d similar to a, b
except that 5 mM 4-MP has been added to the medium simultaneous with EtOH (c n for 4-MP and EtOH+4-MP is 29 and 28; d n for 4-MP and EtOH
+4-MP is 37). e, f similar to a, b except that 10 μM ALDA-1 has been added to the medium simultaneously with EtOH e n for ALDA-1 and EtOH
+ALDA-1 is 27 and 28; f n for ALDA-1 and EtOH+ALDA-1 is 37) (n= 4)
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these factors might be involved in the suppression of
mitochondrial dynamics. First, we compared ΔΨm values,
before and after mitochondrial Ca2+ uptake in VL-17A
and HepG2 cells. Both HepG2 and VL-17A cells showed
similar ΔΨm before and after Ca
2+ addition, and no
change in ΔΨm occurred when they were exposed to
EtOH (Fig. 5a). Mitochondrial Ca2+ uptake was also
unaffected by chrEtOH (Fig. 5b).
We also investigated if EtOH metabolites or generated
ROS might affect the levels of the fusion proteins.
Western blots (Fig. 5c) and the quantiﬁcation of relevant
bands (Figure S3) showed no decrease in the abundance
of Mfn1/2, Opa1 in HepG2 and VL-17A cell lines
exposed chronically to EtOH. Thus, EtOH-induced
ROS suppresses mitochondrial fusion dynamics inde-
pendent of ΔΨm, Ca
2+ handling and the abundance of
fusion proteins.
We have already shown that ROS can sensitize cells
to tBid-induced OMMP27. Based on the above results,
we were wondering whether EtOH also sensitizes the cells
to tBid primarily through its metabolism. We ﬁrst set
out to study the effect of EtOH on HepG2 cells that
we considered as a “negative control” because of the
lack of ADH and CYP2E1 enzyme activity21,22.
EtOH sensitizes HepG2 and heart-derived H9c2 cells to
tBid-induced OMMP and cell death
To study the direct effect of EtOH on tBid-induced
cell death, HepG2 cells were pretreated with either 0 or
100mM EtOH for 72 h. Zero or 30 μM cell permeable Bid
BH3 peptide (Bid BH3cp)28 was added to each in the last
2 h before cell viability was tested. Viability was reduced
by ~ 20% in cells exposed to either EtOH or Bid BH3cp
alone, and by ~ 60% when Bid BH3cp was added to the
cells that were pretreated with EtOH, indicating that
unexpectedly, EtOH independent of its metabolism, sen-
sitizes the cells to tBid-induced cell death (Fig. 6a).
To study the involvement of mitochondria directly,
tBid was added to EtOH-pretreated and untreated plasma
membrane-permeabilized HepG2 cells in suspension.
tBid-induced OMMP was measured as cytochrome c
(cyto c) redistribution from mitochondria to cytosol and
ΔΨm collapse measured in the presence of oligomycin.
Addition of a high concentration of tBid, 100 nM, resulted
in a complete ΔΨm loss with half-maximal response ~ 50 s
in both EtOH-pretreated and untreated cells (Fig. 6b).
Addition of 2.5 nM and less tBid caused delayed ΔΨm
dissipation with a slower rate (Fig. 6c). Under this con-
dition, ΔΨm dissipates faster in EtOH-treated cells com-
pared with naive. The difference between EtOH-treated
and untreated cells was more striking at lower tBid con-
centrations (i.e., 0.5 nM and 0.25 nM). In fact, this con-
centration of tBid caused mitochondrial depolarization
only in EtOH-pretreated cells (Fig. 6c). Figure 6d shows
the tBid dose–response relationship for both untreated
cells and EtOH-pretreated ones and reveals a leftward
shift in the EtOH condition. To study the distribution of
cyto c, cytosolic and membrane fractions were separated
and the purity of each fraction was assessed by α-Tubulin,
mitochondrial HSP70, and Prohibitin as cytosolic or
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mitochondrial marker (Figure S4A). Western blot analysis
of cytosolic fractions conﬁrmed that addition of high
tBid for 5 min results in similar cyto c release in both
EtOH and untreated cells (Fig. 6e). Because the release
of cyto c is an earlier event than the ΔΨm collapse,
whereas EtOH-treated cells showed higher sensitivity to
ΔΨm collapse after addition of 2.5 nM tBid for 5 min,
both EtOH-exposed and non-exposed cells showed
similar cyto c release (Fig. 6e). With lower concentrations
of tBid (0.25 and 0.5 nM) in short/long time points, a
larger fraction of cyto c was released in the EtOH-
pretreated samples (Fig. 6). To assess whether EtOH
favors the release of multiple IMS pro-apoptotic proteins,
Smac/Diablo release was also tested in the tBid-treated
samples using western blot. High concentrations of tBid
(2.5, 100 nM for 5 min) released Smac/Diablo similarly
in both EtOH and mock-pre-exposed samples but in
response to a submaximal concentration of tBid (0.5 nM)
the EtOH-preexposed sample showed more release of
Smac (Figure S4B). Collectively, these results show that
EtOH sensitizes HepG2 cells to tBid-induced OMMP and
release of multiple IMS proteins.
To test whether this phenomenon is cell line speciﬁc,
we pretreated rat cardiac myoblasts, H9c2 cells, with
EtOH for 72 h. H9c2 cells are more sensitive to tBid than
HepG2 cells. As Figure S4C shows, a maximally effective
dose of 2.5 nM tBid (as high concentration) caused ΔΨm
dissipation with similar onset and kinetics in EtOH-
pretreated or control cells with half-maximal response
around 50 s. However, similar to HepG2 cells, a sub-
threshold concentration of tBid (0.032 nM) for the control
caused ΔΨm loss in 40 or 80mM EtOH-pretreated cells
(Figure S4D). The velocity of depolarization depended on
the EtOH concentration. Accordingly, low doses of tBid
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release cyto c only in EtOH-treated cells (Figure S4E).
Thus, EtOH promotes tBid-induced OMMP in both
HepG2 and a cell line derived from a tissue with little
capacity to metabolize EtOH.
EtOH sensitizes to tBid through Bcl-2 family proteins
and independent of PTP opening
To test whether the EtOH-mediated sensitization effect
requires PTP opening, we repeated the experiments
shown in Fig. 6b both in the presence or absence of
cyclosporine A (CSA), a PTP inhibitor (Fig. 7a). CSA
failed to inﬂuence the onset or velocity of tBid-induced
ΔΨm depolarization. To clarify if the effect of EtOH
was mediated through Bcl-2 family proteins we used
recombinant Bcl-xL29. Addition of anti-apoptotic Bcl-xL
(2 μM) repressed tBid-induced ΔΨm loss in both the
presence and absence of EtOH (Fig. 7a). Immunoblotting
against cyto c and Smac showed that the tBid-induced
cyto c/Smac relocation to the cytoplasm in both EtOH-
exposed and non-exposed cells was unaffected by CSA
treatment (Fig. 7b) and was blocked by Bcl-xL addition.
Collectively, this shows that EtOH does not engage in
PTP formation and likely facilitates pro-apoptotic Bcl-2
family proteins to respond to tBid.
EtOH does not alter DRP1 expression or localization
DRP130,31 and OPA1 proteins32 both are associated with
the control of cyto c release. We have already shown that
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EtOH does not alter OPA1 level (Fig. 5c and S3) and
we show in Fig. 7c that DRP1 was mainly in the cytosolic
fraction of HepG2 cells and its abundance was unaffected
by prolonged EtOH exposure.
EtOH-dependent sensitization of tBid-induced OMMP is
insensitive to ROS scavenging by Trolox
As shown in Fig. 3, there is no change in the ratio of
GSSG to GSH in EtOH-treated HepG2 cells suggesting
that global ROS was not increased; however, this did not
exclude a local ROS increase close to the mitochondria.
To test the involvement of ROS, cells were pretreated
with/without 50 μM Trolox simultaneously with EtOH.
Treatment with Trolox failed to suppress EtOH’s effect
on tBid-induced cyto c release and mitochondrial
depolarization (Fig. 8a–c). In fact, Trolox exerted some
sensitization to tBid-induced OMMP both in the absence
and presence of EtOH treatment. This set of data further
supports that the inﬂuence of EtOH on OMMP is not
mediated through ROS.
Prolonged exposure to EtOH is required to sensitize tBid-
induced OMMP
Next, we studied whether EtOH acts instantaneously
or long-term EtOH exposure was needed. HepG2 cells
were exposed to both chrEtOH (72 h) and acute EtOH
and ΔΨm and cyto c release were recorded upon tBid
treatment. Although chrEtOH sensitized cells to tBid,
acute exposure failed to show any effect on tBid-induced
OMMP (Fig. 8d–f).
EtOH’s facilitation of the tBid pathway is independent
of its metabolism
To test whether metabolism of EtOH enhances the
sensitization to tBid we studied VI-7 and VL-17A cells.
As shown before for HepG2 (Figs. 6–8), EtOH-
pretreatment of VI-7 resulted in higher tBid-induced
depolarization velocity and cyto c release (Fig. 9a, c, d).
Untreated VL-17A were more sensitive to tBid than VI-7,
but unexpectedly, EtOH failed to sensitize tBid-induced
OMMP (Fig. 9b–d) and actually, in this condition EtOH-
exposed VL-17A showed slower depolarization and less
cyto c release (Fig. 9d). When the tBid treatment was
more prolonged (480 s), both HepG2 and VL-17A showed
a similar level of cyto c in the presence or absence
of EtOH.
To further explore this, we studied whether EtOH
promoted the interaction of tBid with the OMM. Western
blotting against Bid (Fig. 9e), showed similar amounts
of the added tBid in the membrane fraction of EtOH-
exposed and non-exposed cells, indicating that tBid
interaction with the membrane was unchanged by EtOH.
Using a cross-linker, we found that tBid-induced OMMP
is mainly the result of Bak and not Bax oligomerization in
VI-7 and that EtOH exposure increases Bak oligomer-
ization in this cell type (Fig. 9f). By contrast, EtOH-
exposed VL-17A showed lesser Bak oligomerization
compared with the controls. In addition, only in VL-17A,
tBid induced Bax oligomerization, which was suppressed
in EtOH-exposed VL-17A (Fig. 9f, lower).
Finally, we asked if EtOH treatment would alter the
amount of Bcl-2 family proteins required to sensitize cells
to tBid. Most of the relevant Bcl-2 family members in
the tBid-OMMP pathway (Bak, Bcl-xL, and Mcl-1) did
not show any differences in the protein levels (Fig. 9g).
One exception is that Bax levels were relatively high in
untreated VL-17A cells, and that was reduced after
EtOH treatment (Fig. 9g, S5A). Another mechanism for
the sensitizing effect of chrEtOH could be an elevation
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of endogenous tBid or Bim, which might occupy the
anti-apoptotic Bcl-2 family proteins. However, quantiﬁ-
cation of BimEL, BimL, BimS, and tBid showed no change
upon EtOH treatment (Figure S5B).
Collectively, the results on HepG2/VI-7 vs VL-17A
indicate that EtOH sensitizes tBid-induced OMMP
independent of EtOH metabolism and changes in levels of
Bcl-2 family proteins. The effect of EtOH is downstream
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of tBid association to the OMM, and likely occurs at the
level of Bak oligomerization. Furthermore, the results also
revealed a relatively high tBid sensitivity in VL-17A cells
possibly owing to higher Bax abundance and tBid-induced
Bax oligomerization. Unexpectedly, only in the EtOH-
metabolizing condition, Bax was downregulated, and both
Bak and Bax oligomerization are attenuated.
Discussion
We studied the effect of EtOH-induced stress on
mitochondrial fusion and mitochondrial apoptosis in VL-
17A cells that serve as a simpliﬁed model of hepatocytes,
and HepG2/VI-7 cells lacking the EtOH-metabolizing
enzymes. Previously, the effect of chrEtOH on intracel-
lular signaling and dynamics was investigated mainly in
EtOH-fed animal models, in which EtOH effects might be
inﬂuenced by several other factors or in cell lines that do
not metabolize EtOH. The present paradigm allows direct
application of EtOH to cell types, which are identical
except the difference in EtOH-metabolizing enzymes.
We showed that EtOH metabolism in VL-17A leads to
ROS elevation in the mitochondrial compartment but
in HepG2, EtOH fails to increase mitochondrial ROS.
As the ROS elevation is conﬁned to the mitochondria,
the reason of ROS elevation can be an increase in the
respiratory chain activity, change in the redox state
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(change in NAD/NADH ratio) and reduction of
antioxidants-like superoxide dismutase33 and elevation
of Glutamate dehydrogenase activity34. Using a ROS
scavenger, we linked EtOH-induced suppression of
mitochondrial dynamics to ROS generation.
We documented that mitochondrial fusion is sup-
pressed in VL-17A cells upon chrEtOH similar to hepa-
tocytes17 without a change in fusion protein levels.
Therefore, we reason that a change in the lipid membrane
or translated fusion proteins or mitochondrial positioning
affected fusion activity. ROS elevation might result in
lipid peroxidation or addition of residues (like HNE) to
lipids followed by alteration in the physiochemical prop-
erties of the membranes. Evidence has been presented
that EtOH causes modiﬁcation of cardiolipin in the
liver35,36. Cardiolipin has also been described as a factor
required for both OPA1-mediated IMM fusion37 and
MFN-mediated OMM fusion38. In addition, cardiolipin
interacts with DRP1 to facilitate ﬁssion39, and is needed
for crista formation40. Thus, the EtOH-induced fusion
suppression might involve modiﬁcation of cardiolipin but
because of the wide range of cardiolipin-dependent pro-
cesses, this possibility is difﬁcult to directly test.
Whereas reduced mitochondrial fusion in VL-17A was
independent of fusion proteins levels, we showed that in
skeletal muscle ﬁbers16 extracted from chrEtOH-fed rats,
mitochondrial fusion was suppressed through a decrease
in MFN1 protein level. Both skeletal muscle and brain
have little capacity to metabolize EtOH. Dysregulation of
ΔΨm or Ca
2+ transport could also cause a decrease
in mitochondrial fusion. In hepatocytes isolated from
EtOH-fed animals, Gaspers et al.41 reported higher levels
and uptake of mitochondrial Ca2+, attributed to higher
expression of VDAC (voltage-dependent anion channel)
and MCU (mitochondrial Ca2+ uniporter) proteins.
However, in VL-17A or HepG2 cells, EtOH treatment did
not change mitochondrial Ca2+ uptake or ΔΨm excluding
the role of these factors in fusion inhibition.
Toxicity depends on the concentration and exposure
time of EtOH. High doses of EtOH lead to mitochondrial
Ca2+ overload, ΔΨm dissipation, release of cyto c, and cell
death42. In this study, 80–100mM EtOH for 48–72 h
caused only a small increase in cell death in HepG2 cells.
No sign of PTP formation or cyto c release were detected,
as in43,44. However, we showed that EtOH sensitizes
HepG2 cells to tBid-induced OMMP and cell death.
Pastorino et al.45 have already shown that EtOH can
potentiate mitochondrial membrane permeabilization by
TNF-α, upstream of tBid in HepG2 cells, however; they
showed that this effect is independent of caspase-8, which
is needed for activation of Bid to tBid. Thus, EtOH seems
to sensitize cells to TNF-α-dependent pathways in mul-
tiple ways. Along this line, it is likely that EtOH would
affect mitochondrial cell death induced by drugs with
many cellular targets, including the Bak/Bax pathways like
staurosporine and etoposide but this effect would not
be speciﬁc to the tBid-Bak pathway.
EtOH can directly target cellular membranes and causes
disordering, disrupting, or altering of the physical shape
of the membrane and therefore changing the ultra-
structure of mitochondria. However, as short-term EtOH
exposure does not promote tBid-induced OMMP in
HepG2 cells, acute effects on the membranes are not
the reason for EtOH-induced sensitivity to tBid. As cyto c
is located in the cristae, it is possible that EtOH-induced
morphology impairs the interaction between cyto c and
its binding partner in IMM. In animals, chrEtOH stiffens
the membranes by increasing cholesterol and saturated
lipids13. In mitochondrial membranes, cardiolipin confers
resistance to EtOH36. The potential alterations in lipids
may be relevant for the tBid-induced OMMP. On the
other hand, EtOH might interact with proteins in the
membrane and change their conformation46. Indeed, in
another paradigm, EtOH has been described to associate
with phospholipase C and interfere with PLC/D mediated
signal transduction47,48.
EtOH has been described to alter Bcl-2 family proteins
at the level of mRNA or protein42,49–52. However, we only
found Bax levels affected in VL-17A. Furthermore, EtOH
has been proposed to affect the post-translational mod-
iﬁcation of proteins in non-metabolizing cells53,54 that
might also contribute to tBid-induced OMMP. Recently,
Sariyer et al.55 showed that in neuronal cells chrEtOH
exposure causes Mcl-1 missplicing and reduces the anti-
apoptotic isoform of Mcl-1 but our data did not show this
in HepG2 cells. The most relevant mechanistic ﬁnding
here was that chrEtOH facilitated the tBid-induced
Bak oligomerization that alone can explain the increased
OMMP in HepG2 cells.
EtOH has been reported to enhance membrane per-
meability of mitochondria isolated from hepatocytes upon
stimuli like high Ca2+, Bax protein, Ceramide etc56.
Because EtOH-metabolizing VL-17A cells display ele-
vated ROS and ROS were shown to sensitize the cells to
tBid-induced cell death27, EtOH was anticipated to
potentiate tBid/Bak-induced death in VL-17A cells. This
idea was also supported by data on VL-17A cells that
upon exposure to EtOH, oxidative stress, caspase 3 acti-
vation, and cell death were observed44,57. Surprisingly, we
found that chrEtOH exposure desensitized VL-17A to
tBid-induced OMMP. Bax, a target of tBid is high in
VL-17A cells but, Bax was reduced after chrEtOH like
in hypoxia/reoxygenated brain58, providing a plausible
explanation for inhibition of tBid-induced OMMP. It is
worth noting that VL-17A treated with EtOH showed less
mitochondrial connectivity and dynamics (Fig. 1) and in
the same condition, it showed less Bax level and therefore
less sensitivity to tBid-induced OMMP (Fig. 9). These two
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responses are not in conﬂict with each other as, e.g.,
mitochondria in Mfn1/2 KO MEFs are desensitized to
tBid-induced OMMP59. Furthermore, Hoppins et al.60
showed that cytosolic Bax positively regulates mitochon-
drial fusion, which might explain that a decrease in both
total Bax and elongated mitochondria appear together in
EtOH-treated VL-17A cells. In addition, fragmentation is
not necessarily less healthy condition, e.g., in the pro-
survival phenomenon of autophagy mitochondrial frag-
mentation seems to be necessary61.
Our work described two different effects of chrEtOH-
induced stress on mitochondria, which are oppositely
dependent on EtOH metabolism. ChrEtOH by itself can
exert some suppression of mitochondrial fusion but pro-
ducts of EtOH metabolism, acetaldehyde and ROS, exert a
more profound inhibition. On the other hand, EtOH by
itself sensitizes Bid-induced apoptosis independent of
ROS and the products of EtOH metabolism seem to have
an opposite effect. These observations might have medical
signiﬁcance in the injury of the various tissues in alco-
holics. The metabolism-dependent effects have to be
most prominent in the liver, whereas the ones caused by
EtOH by itself should dominate in skeletal-or cardiac
muscle. Although we got some clues to the targeting of
MFN1 and BAK by EtOH, further efforts will be needed to
decide if alteration of lipid proﬁles or post-translational
modiﬁcation of proteins plays a role in these mitochon-
drial stress responses.
Materials and methods
Chemicals
Cell permeable Bid BH3 peptide (Bid BH3cp) ([Arg](9)-
Gly-Glu-Asp-Ile-Ile-Arg-Asn-Ile-Ala-Arg-His-Leu-Ala-
Gln-Val-Gly-Asp-Ser-Met-Asp-Arg) was purchased from
Selleckchem. tBid was produced as described29. Bismalei-
midohexane (BMH) was from Pierce. G418 was from Enzo,
Zeocin from Invitrogen. ALDA-1 from Tocris. Other che-
micals except the speciﬁed ones were from Sigma.
Cell lines, medium, and treatments
HepG2 cells (ATCC) were grown in minimum essential
medium (ATCC) supplemented with 10% fetal bovine
serum (FBS) (Gibco), 100 U/ml penicillin, 100 μg/ml
streptomycin, and 2mM Glutamine (Gibco) and kept
in 37 °C and 5% CO2. Two modiﬁed HepG2 cell lines:
(1) VL-17A cells expressing active murine alcoholic
dehydrogenase class I (ADH) and human cytochrome
P4502E1 (CYP2E1) similar to normal hepatocytes, and
(2) VI-7 cells, that carry only one empty vector (Zeocin+)
were from Dr. Dahn Clemens (Nebraska University,
Omaha)23,44,62. VI-7 and VL-17A were cultured in the
same medium as HepG2 with 400 μg/ml Zeocin for both
(1) and (2) and with 400 μg/ml G418 antibiotics for (1). As
neither HepG2 nor VI-7 show ADH and CYP2E1 activity
and both cell lines show negligible EtOH metabolism
activity21,22 (Figure S1), and similar mitochondrial
dynamic activity (Figure S2) the presence of Zeocin in the
culture medium does not seem to alter these activities
and in the study of mitochondrial dynamics (Figs. 1–5) we
could use HepG2 cells as the primary control. In the
study of tBid sensitivity both HepG2 (Figs. 6–8) and VI-7
(Fig. 9) cells were used as control for VL-17A cells.
H9c2 cells (ATCC) were maintained as it was described
before20,27. In acute treatments, 50–100 mM EtOH was
added immediately before the experiment and in chronic
treatments 50–100mM EtOH was added for 48–72 h to
the cells medium with every 12 h refreshments and every
24 h replacement. Plates were sealed to avoid EtOH eva-
poration. Trolox (50 μM), 4-MP (5 mM), and ALDA-1
(0.010 mM) treatments were performed at the same time
as EtOH was administered.
Transient expression
DNA transfection was performed using either XTre-
meGene9 (Roche) or Lipofectamine 3000 (Invitrogen) in
accordance with the manufacturers’ protocols 24–48 h
before imaging. The following plasmids were used:
mtDsRed (Takara Bio Inc.) and mtPA-GFP63, which used
the targeting sequence of cyto c oxidase subunit VIII.
Grx1-roGFP264, which is targeted to either cytosol or
mitochondria using a signal sequence from Neurospora
crassa ATP synthase protein 9.
Live-cell microscopic imaging
Fluorescence spreading experiments were performed
on a LSM780 microscope with a × 63 oil objective (Carl
Zeiss), recording 512 × 512 pixel image pairs at 0.25 s−1.
A Chameleon laser (760 nm, Coherent) was used for two-
photon photoactivation of mtPA-GFP25. An argon laser
source was used for imaging of mtPA-GFP at 488 nm and
a DPSS laser at 568 nm for mtDsRed (Takara Bio). Image
analysis was performed using Spectralyzer (MitoCare
proprietary) software and/or Image-J (imagej.nih.gov).
ROS measurements were performed with an inverted
epiﬂuorescence microscope (Olympus) with a × 40 oil
objective connected to a cooled CCD camera (PXL,
Photometrics). Ratiometric imaging was performed at
490 nm and 415 nm, recording 512 × 512 or 256 × 256
pixel image pairs at 0.1 s−1. Calibration of the probe was
performed by adding 2 mM DTT for minimal ratio value
and 0.2 mM H2O2 for maximal ratio value. All the
experiments were performed in extracellular matrix
containing 0.25% bovine serum albumin at 37 °C.
Bioluminescent viability assay
HepG2 cells were seeded in 24-well plate (24,000/well),
treated with EtOH as it described in “Cell lines, medium,
and EtOH treatment”. In the last 2 h, cells were treated
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with Bid BH3cp in the cell medium described above
except that it was supplemented with 2% FBS. The cell
viability measured using CellTiter-Glo Luminescent Cell
Viability Assay (Promega).
ΔΨm measurement, cyto c release assay, and Ca
2+
recording in cell suspension
ΔΨm was recorded using ﬂuorometer (DeltaRAM;
Horiba, NewJersey, USA) with either TMRM (1.5 μM) or
JC-1 (0.8 μM) as described27,65,66. Cells were harvested
and washed with cold Na-Hepes-EGTA buffer containing
120mM NaCl, 5 mM KCl, 1 mM KH2PO4, 0.2 mM
MgCl2, and 20 mM Hepes-NaOH, pH 7.4. In 37 °C and
under stirring condition, the same aliquots of cells
(1.2–2.4 mg) were permeabilized using 30–40 μg/ml
Digitonin in 1.5 ml intracellular medium buffer (ICM:120
mM KCl,10 mM NaCl,1 mM KH2PO4, 20 mM Hepes-
Tris, pH 7.2) supplemented with 5 μg/ml protease inhi-
bitors leupeptin, antipain, and pepstatin for 5 min. In all
the experiments, 2 mM MgATP, 2 mM succinate, and 5
μg/ml oligomycin were present. Digitonin 600 μg/ml was
used to release total cyto c from the mitochondria.
Uncoupler, FCCP (5 μM) was applied at the end of each
run to dissipate remaining ΔΨm. JC-1 was used as the
ratio of the aggregated dye intensity (570 nm excitation/
595 nm emission) to monomeric dye (490 nm excitation/
535 nm emission) and TMRM with 540 nm excitation and
580 nm emission. After each run samples were cen-
trifuged for 5 min at 10,000×g and cytosolic and mem-
brane fractions were separated. For Ca2+ measurements,
2 μM thapsigargin (Enzo) and 1.0 μM fura2FF (Kd= 4.5
μM, TEFLabs) were added to ICM, which was supple-
mented as explained above without oligomycin. Calibra-
tion for maximum and minimum fura2FF response was
performed by adding 1mM Ca2+ and 10M EGTA/TRIS
pH 8.5, respectively.
Western blotting
Intact cells or membrane fraction (pelleted by cen-
trifuging permeabilized cell suspensions at 10,000 × g for
5 min) were lysed in cold radioimmunoprecipitation assay
buffer, (150 mM NaCl, 1.0% (vol/vol) Octylphenox-
ypolyethoxyethanol, 0.5 % sodium deoxycholate, 0.1 %
sodium dodecyl sulphate, and 50mM Tris (pH 8.0;
Sigma)), supplemented with 1 μg/ml protein inhibitors
(leupeptin, antipain, and pepstatin) and 1mM phe-
nylmethylsulfonyl ﬂuoride. Lysed samples and cytosol
fractions were used for immunoblotting. Western blot
was performed based on instructions of LI-COR (LI-COR
Corporation, Nebraska, USA). Primary antibodies used
were Anti-BAK (no. 06-536; Millipore) Anti-cyto c (no.
556433; BD Bioscience), Anti-HA (no. 9110; Abcam),
Anti-mtHsp70 (no. MA3-028; Thermo Scientiﬁc), and
Anti-prohibitin (no. ab28172; Abcam), anti-Bax (N-20, sc-
493, SantaCruz), anti-MCL-1 (ADI-AAP-240, Enzo life
sciences), anti-Bid (no. AF860, R&D systems), anti-Bim
(no.2933, Cell Signaling), anti-Bcl-xL (no. 610211, BD
transduction), anti-Actin (no.612656, BD transduction),
anti-Calnexin (no. ADI-SPA-860, Enzo Life sciences).
Detection of bands was performed on a LI-COR Odyssey
scanner. ImageJ was used for quantiﬁcation of the bands.
Oligomerization assay
Oligomerization has been performed as described pre-
viously27. In brief, pellet fractions from “ΔΨm measure-
ment and cyto c Release Assay” section were treated with
10mM freshly prepared cross-linker, BMH, for 30 min
and then reaction was stopped with 20mM Tris (pH 7.5).
Samples were lysed as described in western blot section.
Statistics
Samples were run as duplicates or triplicates. All
experiments were repeated at least three times. Statistical
signiﬁcance was calculated using two-way ANOVA.
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